Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CASTIGLIONEGERTSCH M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 24 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. COLLEONI M; PRICE K; CASTIGLIONEGERTSCH M; GOLDHIRSCH A; COATES A; LINDTNER J; COLLINS J; GELBER RD; THURLIMANN B; RUDENSTAM CM
      DOSE-RESPONSE EFFECT OF ADJUVANT CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) IN NODE-POSITIVE BREAST-CANCER

      European journal of cancer
    2. PINDER SE; MURRAY S; ELLIS IO; TRIHIA H; ELSTON CW; GELBER RD; GOLDHIRSCH A; LINDTNER J; CORTESFUNES H; SIMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M
      THE PREDICTION OF RESPONSE TO CHEMOTHERAPY IN INVASIVE BREAST-CARCINOMA BY DETERMINATION OF HISTOLOGICAL GRADE

      European journal of cancer
    3. CASTIGLIONEGERTSCH M
      BREAST-CANCER CLINICAL-TRIALS IN EUROPE - WHAT HAS BEEN DONE AND WHATIS CURRENTLY UNDERWAY

      European journal of cancer
    4. GOLDHIRSCH A; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
      NEW TREATMENTS FOR BREAST-CANCER - BREAKTHROUGHS FOR PATIENT-CARE OR JUST STEPS IN THE RIGHT DIRECTION

      Annals of oncology
    5. GOLDHIRSCH A; COLLEONI M; COATES AS; CASTIGLIONEGERTSCH M; GELBER RD
      ADDING ADJUVANT CMF CHEMOTHERAPY TO EITHER RADIOTHERAPY OR TAMOXIFEN - ARE ALL CMFS ALIKE

      Annals of oncology
    6. CASTIGLIONEGERTSCH M
      REVIEW OF BREAST-CANCER TRIALS IN EUROPE - DURABLE ACHIEVEMENTS, FUTURE STUDIES

      Annals of oncology
    7. GOLDHIRSCH A; COATES AS; COLLEONI M; CASTIGLIONEGERTSCH M; GELBER RD
      ADJUVANT CHEMOENDOCRINE THERAPY IN POSTMENOPAUSAL BREAST-CANCER - CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL DOSE AND SCHEDULE MAY MAKE A DIFFERENCE

      Journal of clinical oncology
    8. BERNHARD J; PETERSON HF; COATES AS; GUSSET H; ISLEY M; HINKLE R; GELBER RD; CASTIGLIONEGERTSCH M; HURNY C
      QUALITY-OF-LIFE ASSESSMENT IN INTERNATIONAL BREAST-CANCER STUDY-GROUP(IBCSG) TRIALS - PRACTICAL ISSUES AND FACTORS ASSOCIATED WITH MISSINGDATA

      Statistics in medicine
    9. PINDER SE; MURRAY S; ELLIS IO; TRIHIA H; ELSTON GW; GELBER RD; GOLDHIRSCH A; LINDTNER J; CORTESFUNES H; SIMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M; GUSTERSON BA
      THE IMPORTANCE OF THE HISTOLOGIC GRADE OF INVASIVE BREAST-CARCINOMA AND RESPONSE TO CHEMOTHERAPY

      Cancer
    10. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GALLIGIONI E; MARINI G; THURLIMANN B; FORBES JF; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
      FACTORS AFFECTING BASE-LINE QUALITY-OF-LIFE IN 2 INTERNATIONAL ADJUVANT BREAST-CANCER TRIALS

      British Journal of Cancer
    11. BERNHARD J; HURNY C; PETERSON HF; GELBER RD; CASTIGLIONEGERTSCH M; COATES AS
      QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER

      Quality of life research
    12. CASTIGLIONEGERTSCH M; TATTERSALL M; HACKING A; GOLDHIRSCH A; GUDGEON A; GELBER RD; LINDTNER J; COATES A; COLLINS J; ISLEY M; SENN HJ; RUDENSTAM CM
      RETREATING RECURRENT BREAST-CANCER WITH THE SAME CMF-CONTAINING REGIMEN USED AS ADJUVANT THERAPY

      European journal of cancer
    13. BERNHARD J; HURNY C; COATES AS; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; GOLDHIRSCH A; SENN HJ; RUDENSTAM CM
      QUALITY-OF-LIFE ASSESSMENT IN PATIENTS RECEIVING ADJUVANT THERAPY FORBREAST-CANCER - THE IBCSG APPROACH

      Annals of oncology
    14. PESTALOZZI BC; PETERSON HF; GELBER RD; GOLDHIRSCH A; GUSTERSON BA; TRIHIA H; LINDTNER J; CORTESFUNES H; SIMMONCINI E; BYRNE MJ; GOLOUH R; RUDENSTAM CM; CASTIGLIONEGERTSCH M; ALLEGRA CJ; JOHNSTON PG
      PROGNOSTIC IMPORTANCE OF THYMIDYLATE SYNTHASE EXPRESSION IN EARLY BREAST-CANCER

      Journal of clinical oncology
    15. CASTIGLIONEGERTSCH M; GOLDHIRSCH A; GUSTERSON B; BETTELHEIM R; REED R; GUSSET H; GEISER K; HURNY C; BERNHARD J; HANGARTNER A; MAIBACH R; PEDOWSKI R; GELBER R; PRICE K; PETERSON H; ZELEN M; ISLEY M; HINKLE R; KAY RG; HOLDAWAY IM; HARVEY VJ; JAGUSCH MF; NEAVE L; MASON BM; EVANS B; BENJAMIN CS; CARTER JF; GILLMAN JC; MACK D; BENSONCOOPER D; MONFARDINI S; GALLIGIONI E; CRIVELLARI D; BUONADONNA A; MASSARUT S; ROSSI C; CANDIANI E; CARBONE A; VOLPE R; TROVO MG; RONCADIN M; SANTINI GF; VILLALTA D; CORAN F; MORASSUT S; MARINI G; SIMONCINI E; MARPICATI P; ZANIBONI A; SARTORI U; BARNI A; CERUTTI L; ALGHISI A; RAFFAGLIO E; GARATTINI MP; ALBERTINI A; GRIGOLATO F; MORASSI L; BERGONZINI R; LAURIOLA C; GUDGEON A; DENT DM; TILTMAN A; HACKING A; DOWDLE E; STEYNOR P; TOOP J; SCHNURCH HG; MOSNY D; BENDER HG; BOJAR H; VERONESI A; FOLADORE S; PAMICH G; BIANCHI G; TORRETTA A; RUDENSTAM CM; WALLGREN A; PERSSON S; MATTSSON J; CAHLIN E; HAFSTROM LO; HOLMBERG S; HULTBORN R; COLLDAHLJADERSTROM G; GUSTAVSSON B; CARLSSON G; IVARSSON L; THOREN O; RUUSVIK O; NICKLASSON LG; DAHLIN S; KARLSSON G; LINDBERG B; SUNDBACK A; BERGEGARDH S; SALANDER H; ANDERSSON C; HESSMAN Y; NELZEN O; HEIDEMAN M; RAMHULT T; SVENSSON JH; LIDBERG P; BJORK S; LINDTNER J; ERZEN D; CERAR O; STABUC B; GOLOUH R; LAMOVEC J; SEBEK S; KRAMBERGER M; VRHOVEC I; CORTESFUNES H; MARTINEZTELLO F; MENDIOLA C; CRUZVIGO F; LARRODERA ML; SIERRA A; MIRANDA P; ALONSO S; COLLINS J; SNYDER R; GREGORY P; BURAS WI; GREEN M; GALE T; HENDERSON M; HART S; NEIL S; KITCHEN P; LOVELL R; MCLENNAN R; REED R; RUSSELL I; SCHWARZ M; BASSER R; ROBERTSON A; GILL P; CARTER ML; MALYCHA P; YEOH E; WARD G; LEONG ASY; LOMMAXSMITH J; HOOSFALL D; DANGELO R; BYRNE M; VANHAZEL G; DEWAR J; BUCK M; SHEINER HJ; INGRAM D; STERRETT G; HAHNEL R; FORBES JF; STEWARD J; DARBAR SW; BISHOP JM; SIMMS B; ZIOGAS V; TATTERSALL MHN; COATES A; NIESCHE F; WEST R; RENWICK S; DONOVAN J; DUVAL P; SIMES RJ; NG A; GLENN D; NORTH RA; BEITH J; OCONNOR RG; RICE M; STEVENS G; FEY M; BARTH A; DREHER E; ISENSCHMID M; SCHNEIDER H; BUSER K; LUDIN J; LUTHI JM; ALTERMATT HJ; LAISSUE JA; MARKWALDER R; BURGI H; SENN HJ; THURLIMANN B; JUNGI WF; MORANT R; OEHLSCHLEGEL C; HARDMEIER T; LUSCHER K; RIES G; TOPFER M; LORENZ U; BENZ D; SCHILTKNECHT O; SPATI B; SCHMID L; CAVALLI F; SESSA C; BRONZ L; MARTINELLI G; MULLER W; LUSCIETI P; PASSEGA E; PEDRINIS E; REY P; MARTINOLI S; SPINELLI A; GALFETTI MA; LOMBARDI A; PEDRAZZINI A; LOSA G; VARINI M; GINIER M; HERRMANN R; HARDER JF; LAFFER U; ALMENDRAL AC; EPPENBERGER U; TORHORST J; SIEGENTHALER P; PIGUET D; BARRELET V; BAUMANN RP; JOSS R; SAUTER C; METZGER U; ENGELER V; HALLER U; KOCHLI O; LEYVRAZ S; PEREY L; ANANI P; GOMEZ F; MIRIMANOFF RO; CHAPUIS G; DEGRANDI P; REYMOND P; ALBERTO P; SCHAFER P; KRAUER F; FORNI M; AAPRO M; EGELI R; MEGEVAND R; JACOTDESCOMBES E; SCHINDLER A; NOSEDA G; WEBER W; LEHMANN W
      EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY IN COMBINATION WITH TAMOXIFEN FOR NODE-POSITIVE POSTMENOPAUSAL BREAST-CANCER PATIENTS

      Journal of clinical oncology
    16. CASTIGLIONEGERTSCH M
      NEW AROMATASE INHIBITORS - MORE SELECTIVITY, LESS TOXICITY, UNFORTUNATELY, THE SAME ACTIVITY

      European journal of cancer
    17. THURLIMANN B; BERETTA K; BACCHI M; CASTIGLIONEGERTSCH M; GOLDHIRSCH A; JUNGI WF; CAVALLI F; SENN HJ; FEY M; LOHNERT T
      FIRST-LINE FADROZOLE HCI (CGS-16949A) VERSUS TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH ADVANCED BREAST-CANCER - PROSPECTIVE RANDOMIZED TRIAL OF THE SWISS-GROUP-FOR-CLINICAL-CANCER-RESEARCH SAKK-20 88/

      Annals of oncology
    18. MARINI G; MURRAY S; GOLDHIRSCH A; GELBER RD; CASTIGLIONEGERTSCH M; PRICE KN; TATTERSALL MHN; RUDENSTAM CM; COLLINS J; LINDTNER J; CAVALLI F; CORTESFUNES H; GUDGEON A; FORBES JF; GALLIGIONI E; COATES AS; SENN HJ
      THE EFFECT OF ADJUVANT PREDNISONE COMBINED WITH CMF ON PATTERNS OF RELAPSE AND OCCURRENCE OF 2ND MALIGNANCIES IN PATIENTS WITH BREAST-CANCER

      Annals of oncology
    19. WALLGREN A; BERNIER J; GELBER RD; GOLDHIRSCH A; RONCADIN M; JOSEPH D; CASTIGLIONEGERTSCH M
      TIMING OF RADIOTHERAPY AND CHEMOTHERAPY FOLLOWING BREAST-CONSERVING SURGERY FOR PATIENTS WITH NODE-POSITIVE BREAST-CANCER

      International journal of radiation oncology, biology, physics
    20. HURNY C; BERNHARD J; COATES AS; CASTIGLIONEGERTSCH M; PETERSON HF; GELBER RD; FORBES JF; RUDENSTAM CM; SIMONCINI E; CRIVELLARI D; GOLDHIRSCH A; SENN HJ
      IMPACT OF ADJUVANT THERAPY ON QUALITY-OF-LIFE IN WOMEN WITH NODE-POSITIVE OPERABLE BREAST-CANCER

      Lancet
    21. HORNY C; BERNHARD J; COATES A; PETERSON HF; CASTIGLIONEGERTSCH M; GELBER RD; RUDENSTAM CM; COLLINS J; LINDTNER J; GOLDHIRSCH A; SENN HJ
      RESPONSIVENESS OF A SINGLE-ITEM INDICATOR VERSUS A MULTIITEM SCALE - ASSESSMENT OF EMOTIONAL WELL-BEING IN AN INTERNATIONAL ADJUVANT BREAST-CANCER TRIAL

      Medical care
    22. GOLDHIRSCH A; CASTIGLIONEGERTSCH M
      ADJUVANT SYSTEM THERAPY FOR BREAST-CANCER

      Archives of gynecology and obstetrics
    23. CASTIGLIONEGERTSCH M; JOHNSEN C; GOLDHIRSCH A; GELBER RD; RUDENSTAM CM; COLLINS J; LINDTNER J; HACKING A; CORTESFUNES H; FORBES J; SIMPSON J; TATTERSALL MHN; BRUNNER K; CAVALLI F; SENN HJ
      THE INTERNATIONAL (LUDWIG) BREAST-CANCER STUDY-GROUP TRIALS I-IV - 15YEARS FOLLOW-UP

      Annals of oncology
    24. CASTIGLIONEGERTSCH M; PAMPALLONA S; VARINI M; CAVALLI F; BRUNNER K; SENN HJ; GOLDHIRSCH A; METZGER U
      PRIMARY ENDOCRINE THERAPY FOR ADVANCED BREAST-CANCER - TO START WITH TAMOXIFEN OR WITH MEDROXYPROGESTERONE ACETATE

      Annals of oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 07:03:48